“…For each particular study, extensive evaluation of study design should be considered to ensure the cost effectiveness of an eDNA- or eRNA-based approach as opposed to traditional approaches, because, as the current costs stand, on the basis of study design, eDNA-based methods can be more expensive than traditional methods and eRNA-based approaches are significantly more expensive than eDNA-based approaches (Smart et al 2016 , Broman et al 2020 , Winkworth et al 2020 ). However, the continued rapid fall in high-throughput sequencing costs, increased multiplexing potential of qPCR or ddPCR (which partitions the sample before amplification, allowing for rare or low-abundance detection), and the development of more cost-effective and resource-conscious methodologies such as LAMP-based assays is bridging these economic gaps (Smart et al 2016 , Broman et al 2020 , Winkworth et al 2020 ). As an example, it has been estimated that when detecting New Zealand mudsnails, an invasive species in the United States, it is four to eight times less expensive to use qPCR-based eDNA approaches—at US$35–$80 per sample—than traditional approaches (collecting, sorting, and identifying samples) that cost US$300 per sample (Goldberg et al 2013 ).…”